Professional and technical services blanket purchase agreement (BPA)
Ended Awarded Last action
- Contract number
- 75F40123F19260
- Awardee
-
Brillient Corporation UEI MMAVC7UGLJ78
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $96,018
Award facts
- Contract value 100% obligated
- $96,018.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Time and Materials
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$7,502 | |
| Other Administrative Action | -$106,208 | |
| Original award | $209,728 |
About this award
This is a $96,018.24 Blanket Purchase Agreement (BPA) awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Brillient Corporation, a minority-owned, for-profit Subchapter S Corporation. The BPA is for professional and technical services and is under the Multiple Award Schedule (MAS) contract vehicle. Brillient Corporation is a leading full-spectrum digital transformation company that provides a range of services to federal agencies, including program management, IT services, engineering, consulting, and administrative support. This BPA award does not have a set-aside designation. Brillient holds several significant federal contract vehicles, including a $55.3 million BPA with the Department of the Treasury Internal Revenue Service and a $58.5 million indefinite delivery contract with the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases.
Quick answers
Who was awarded contract 75F40123F19260?
75F40123F19260 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on November 9, 2022.
How much is contract 75F40123F19260 worth?
The government has obligated $96,018 on 75F40123F19260.
Is contract 75F40123F19260 an order under another contract?
Yes. 75F40123F19260 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40123F19260 competed?
The extent of competition for 75F40123F19260 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award